Why Citron's Andrew Left Is Shorting Tilray

The transcript discusses the volatility and valuation concerns of cannabis stocks, particularly Tilray and Kronos. It highlights the rapid price changes and market reactions, emphasizing the need for investor awareness and caution. The speaker critiques the hype around cannabis investments, warning against uninformed decisions and highlighting the speculative nature of the market.

What is the main concern about the stock that was once valued at $26?

• The company has changed its business model.

• The stock is not traded enough.

• The stock's valuation has become excessive.

• The stock is undervalued.

Why is shorting Tilray considered risky?

• It is a well-understood market.

• It is a stable stock with low volatility.

• The market cap is too large.

• The stock is thinly traded and volatile.

What is the speaker's recommendation for those wanting exposure to the cannabis industry?

• Invest without considering the price.

• Understand the market before investing.

• Short all cannabis stocks.

• Buy stocks based on press releases.

How does the speaker describe Kronos in the cannabis market?

• A series of press releases.

• A company with substantial operations.

• A leading player in the industry.

• A major competitor to Tilray.

What is the speaker's view on the current stage of cannabis investment?

• It is declining rapidly.

• It is a stable investment.

• It is at peak hysteria.

• It is at the early stages.